Physician profile
Andy Phung
NPI 1003013756
$1,360.57
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $134 · 2022: $564 · 2023: $343 · 2024: $319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $662.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $662.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $284.41 | 2021-2024 | Belbuca, Xtampza |
| Abbvie INC. | $220.05 | 2022-2024 | |
| Amgen INC. | $136.86 | 2022 | |
| Novo Nordisk INC | $95.11 | 2021-2024 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $86.69 | 2022-2023 | Mounjaro, Emgality, Reyvow |
| Scilex Pharmaceuticals INC. | $75.58 | 2021-2023 | Ztlido |
| Pfizer INC. | $69.85 | 2021-2024 | |
| Glaxosmithkline, LLC. | $66.69 | 2021-2023 | Shingrix |
| Medtronic, INC. | $57.66 | 2022 | |
| Ironwood Pharmaceuticals, INC | $46.62 | 2022-2023 | Linzess |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $46.51 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $32.35 | 2021-2023 | |
| Azurity Pharmaceuticals, INC. | $22.94 | 2024 | Horizant |
| Painteq LLC | $21.85 | 2024 | Painteq |
| Biohaven Pharmaceutical Holding Company LTD. | $18.51 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $18.38 | 2024 | |
| Forte Bio-Pharma LLC | $16.31 | 2021 | |
| Idorsia Pharmaceuticals US INC | $16.13 | 2024 | Quviviq |
| Tris Pharma INC | $14.86 | 2024 | Dyanavel Xr |
| Amarin Pharma, INC. | $13.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andy Phung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.